Prati
Zong Sheng Guo
Zong Sheng Guo
Roswell Park Comprehensive Cancer Center
Potvrđena adresa e-pošte na Roswellpark.org
Naslov
Citirano
Citirano
Godina
Consensus guidelines for the detection of immunogenic cell death
O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ...
Oncoimmunology 3 (9), e955691, 2014
8332014
Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228
X Yu, ZS Guo, MG Marcu, L Neckers, DM Nguyen, GA Chen, DS Schrump
Journal of the National Cancer Institute 94 (7), 504-513, 2002
4802002
Oncolytic viruses as therapeutic cancer vaccines
DL Bartlett, Z Liu, M Sathaiah, R Ravindranathan, Z Guo, Y He, ZS Guo
Molecular cancer 12, 1-16, 2013
3542013
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Z Liu, R Ravindranathan, P Kalinski, ZS Guo, DL Bartlett
Nature communications 8 (1), 14754, 2017
3242017
Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity
ZS Guo, Z Liu, DL Bartlett
Frontiers in oncology 4, 74, 2014
2832014
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
ZS Guo, SH Thorne, DL Bartlett
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1785 (2), 217-231, 2008
2652008
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
ZS Guo, B Lu, Z Guo, E Giehl, M Feist, E Dai, W Liu, WJ Storkus, Y He, ...
Journal for immunotherapy of cancer 7, 1-21, 2019
2492019
The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells
P Lawinger, R Venugopal, ZS Guo, A Immaneni, D Sengupta, W Lu, ...
Nature medicine 6 (7), 826-831, 2000
2172000
Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes …
TS Weiser, ZS Guo, GA Ohnmacht, ML Parkhurst, P Tong-On, ...
Journal of Immunotherapy 24 (2), 151-161, 2001
2132001
Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
ZS Guo, LH Wang, RC Eisensmith, SL Woo
Gene therapy 3 (9), 802-810, 1996
2131996
Imaging Adenoviral-mediated Herpes Virus Thymidine Kinase Gene Transfer and Expression In Vivo
JG Tjuvajev, S Hsia Chen, A Joshi, R Joshi, Z Sheng Guo, J Balatoni, ...
Cancer research 59 (20), 5186-5193, 1999
2071999
T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy
F Yu, X Wang, ZS Guo, DL Bartlett, SM Gottschalk, XT Song
Molecular Therapy 22 (1), 102-111, 2014
1932014
Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway
YH Kim, DH Lee, JH Jeong, ZS Guo, YJ Lee
Biochemical pharmacology 75 (10), 1946-1958, 2008
1922008
Tumor-specific transcriptional targeting of suicide gene therapy
J Qiao, M Doubrovin, BV Sauter, Y Huang, ZS Guo, J Balatoni, T Akhurst, ...
Gene therapy 9 (3), 168-175, 2002
1762002
First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity
HJ Zeh, S Downs-Canner, JA McCart, ZS Guo, UNM Rao, L Ramalingam, ...
Molecular Therapy 23 (1), 202-214, 2015
1722015
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2
ZS Guo, A Naik, ME O'Malley, P Popovic, R Demarco, Y Hu, X Yin, S Yang, ...
Cancer research 65 (21), 9991-9998, 2005
1662005
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
ZS Guo, JA Hong, KR Irvine, GA Chen, PJ Spiess, Y Liu, G Zeng, ...
Cancer research 66 (2), 1105-1113, 2006
1642006
Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer
J Li, M O'malley, J Urban, P Sampath, ZS Guo, P Kalinski, SH Thorne, ...
Molecular Therapy 19 (4), 650-657, 2011
1462011
Life after death: targeting high mobility group box 1 in emergent cancer therapies
ZS Guo, Z Liu, DL Bartlett, D Tang, MT Lotze
American journal of cancer research 3 (1), 1, 2013
1452013
Phase 1 study of intravenous oncolytic poxvirus (vvDD) in patients with advanced solid cancers
S Downs-Canner, ZS Guo, R Ravindranathan, CJ Breitbach, ME O'malley, ...
Molecular Therapy 24 (8), 1492-1501, 2016
1412016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20